Relief Therapeutics Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLFTD research report →
About the company
Relief Therapeutics Holding AG operates as a biopharmaceutical firm, dedicated to providing vital therapeutic relief to patients suffering from severe diseases for which current medical solutions are insufficient. The company's reach extends across Switzerland, the broader European continent, North America, and various international markets. Its strategic focus is on advancing clinical-stage programs that leverage molecules with a proven history of clinical application.
- CEO
- Jack Weinstein
- IPO
- 2021
- Employees
- 69
- HQ
- Geneva, CH
Price Chart
- Market Cap
- $44.94M
- P/E
- -2.41
- P/S
- 4.29
- P/B
- 1.12
- EV/EBITDA
- -1.40
- Div Yield
- 0.00%
- Gross Margin
- 69.41%
- Op Margin
- -224.37%
- Net Margin
- -203.39%
- ROE
- -38.52%
- ROIC
- -34.28%
- Revenue
- $8.42M · 39.52%
- Net Income
- $-17,119,000 · 82.56%
- EPS
- $-1.36 · 83.71%
- Op Income
- $-18,885,000
- FCF YoY
- 82.90%
- 52W High
- $15.15
- 52W Low
- $3.60
- 50D MA
- $7.49
- 200D MA
- $10.38
- Beta
- -14.14
- Avg Volume
- 38
Get TickerSpark's AI analysis on RLFTD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RLFTD coverage
Recent articles, reports, and earnings notes.
No research on RLFTD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLFTD report →Similar companies
Peers in the same neighborhood.